Navigation Links
Visikol Appoints Pharmaceutical Industry Leader, Stewart Hunt, as Director of US Sales
Date:12/6/2018

Stewart has been on the business side of life science research, selling instruments, consumables and laboratory contract services, throughout his career. During his recent five-year tenure with InSphero he was the US General Manger where he developed a US Sales team and established the commercial laboratory operations in Brunswick, Maine. Through these experiences, Stewart has a deep understanding of the 3D cell culture space from both a business, technical and operational stand point. Stewart has a passion for image-based screening services and brings his dynamic business development skills with over 25 years of life science experience to Visikol.

“At Visikol we have always prided ourselves on our deep relationships with clients and ability to design customized drug discovery solutions for a wide range of needs in the in vitro, imaging and image analysis fields. With bringing on Stewart as our Director of US Sales, we will be able to better serve our clients as well as expand our reach so that we can address new client needs,” described Visikol Director of Operations Brian Mulhall.

Stewart will lead Visikol’s commercial efforts in the US and will be the main point of contact for its pharmaceutical Clients. “Expanding our commercial team is a strong focus of ours as we head into 2019 and we look forward to having Stewart lead these efforts as we continue to build out our imaging, advanced cell culture and image analysis services” described Visikol CEO, Dr. Michael Johnson.

About Visikol
Visikol is a contract research organization that is focused on accelerating drug discovery through the transformation of tissues into actionable and quantitative insights. Visikol is comprised of experts in imaging, digital pathology, machine learning and advanced in vitro models. The company leverages this expertise along with a portfolio of proprietary imaging and image analysis technologies to offer pharmaceutical/biotech companies 3D cell culture assays, digital pathology services, 3D tissue imaging services, high content screening and customized drug discovery solutions. Visikol partners closely with clients in drug discovery efforts and to assist them with using innovative assays for drug screening that are more rapid, reliable, and relevant for screening. In addition to this service offering, Visikol also sells various tissue clearing reagents and kits for researchers that are interested in adopting 3D tissue imaging into their own workflows. For more information about Visikol or its services, please visit our website at visikol.com.

Read the full story at https://www.prweb.com/releases/visikol_appoints_pharmaceutical_industry_leader_stewart_hunt_as_director_of_us_sales/prweb15970931.htm.


'/>"/>
Source: PRWeb
Copyright©2018 Vocus, Inc.
All rights reserved


Related biology news :

1. Visikol Hits Key Milestone, Recognized by Forbes for Passion & Innovation
2. Visikol Co-Founder Michael Johnson named to 2017 Forbes 30 Under 30 List
3. uBiome Appoints Dr. Amir Zarrinpar, MD, PhD, Assistant Professor in the Division of Gastroenterology at UC San Diego, to its Medical Advisory Board
4. uBiome Appoints Dr. Brandon Wuerth, MD, Founder of IBDwatch, to its Medical Advisory Board
5. uBiome Appoints Dr. Emeran Mayer, MD, World-Renowned Gastroenterologist and Neuroscientist, to its Medical Advisory Board
6. uBiome Appoints Dr. Jill Carnahan, MD, Functional Medicine Expert, to its Medical Advisory Board
7. uBiome Appoints Dr. Catherine Lozupone, PhD, Respected Microbiologist, to its Scientific Advisory Board
8. uBiome Appoints Leading Biochemist Dr. Joseph DeRisi to Board of Directors
9. uBiome Appoints Dr. Donnica Moore, MD, Women's Health Expert and Advocate, to its Medical Advisory Board
10. uBiome Appoints Dr. Jonathan Braun, MD, PhD, Prominent UCLA Physician-Researcher, to its Scientific Advisory Board
11. uBiome Appoints Kathie Swift, MS, RDN, FAND, Co-founder of the Integrative and Functional Nutrition Academy, to its Scientific Advisory Board
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/17/2019)... , ... April 17, 2019 , ... ... biostatistics, and other services to clinical trial sponsors, has entered into a multi-year ... agreement will enable Quartesian, a member of Medrio’s Certified Partner Program, to leverage ...
(Date:4/16/2019)... ... 16, 2019 , ... The Healthcare Technology Report is pleased ... extensive process was run to evaluate the hundreds of CEOs that lead exemplary ... other related areas. We gathered data on each nominee’s professional background and assessed ...
(Date:4/12/2019)... ... April 12, 2019 , ... ... from complex microbiota accessible carbohydrates (MACs) as specialty ingredients for the global animal ... Materials Register and commercial launch of its first-in class microbiome modulating prebiotic GNU100, ...
Breaking Biology News(10 mins):
(Date:4/8/2019)... Zealand (PRWEB) , ... April 09, 2019 , ... ... infectious disease, the innovative non-profit research center Chan Zuckerberg Biohub (CZ Biohub) has ... study of antibody repertoires is part of CZ Biohub’s efforts to establish new ...
(Date:3/27/2019)... ... ... In honor of National Nutrition Month, Lajollacooks4u has collaborated with the San Diego ... This month, Chef Jodi Abel appeared on two segments on KUSI’s Good Morning ... addressed the nutritional value of USDA’s MyPlate, a nutrition guide that simplifies the somewhat ...
(Date:3/19/2019)... ... March 19, 2019 , ... ... cloud solutions, today announced it has extended its managed services offering to include ... data centers that are part of the NVIDIA DGX-Ready Data Center program to ...
(Date:3/19/2019)... ... March 19, 2019 , ... Cirrascale Cloud Services ... has begun offering NVIDIA® DGX-1™ deep learning systems as part of its dedicated, ... the highest performance for artificial intelligence and deep learning research and development. , ...
Breaking Biology Technology: